Pages that link to "Q45142785"
Jump to navigation
Jump to search
The following pages link to Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess (Q45142785):
Displaying 50 items.
- Acromegaly (Q21202912) (← links)
- Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation (Q21254711) (← links)
- Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegaly (Q28486006) (← links)
- Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement (Q33736166) (← links)
- Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review (Q33772673) (← links)
- Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life (Q34840936) (← links)
- Surgical management of acromegaly in a resource-challenged environment (Q35041686) (← links)
- Body Image Disturbance in Acromegaly Patients Compared to Nonfunctioning Pituitary Adenoma Patients and Controls (Q35675855) (← links)
- Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea (Q35740478) (← links)
- Osteoarticular changes in acromegaly (Q36248442) (← links)
- Treatment of pituitary tumors: somatostatin. (Q36324189) (← links)
- Long-term health-related quality of life of surgically treated pituitary adenoma patients: a descriptive study (Q36546547) (← links)
- Quality of life in acromegaly (Q36626495) (← links)
- The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary (Q36874748) (← links)
- Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders (Q36916560) (← links)
- Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly (Q37257600) (← links)
- Patient-focussed outcomes in acromegaly (Q37530996) (← links)
- Somatostatin analog and pegvisomant combination therapy for acromegaly (Q37599321) (← links)
- Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues (Q37641076) (← links)
- Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters (Q37678328) (← links)
- Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations (Q37795789) (← links)
- What is active acromegaly and which parameters do we have? (Q37977989) (← links)
- Octreotide long-acting repeatable for acromegaly (Q37990556) (← links)
- Pituitary centers of excellence (Q38035640) (← links)
- Octreotide for acromegaly treatment: a reappraisal (Q38152458) (← links)
- Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies (Q38326160) (← links)
- QOL and work capacity is unrelated to approach or complications after pituitary surgery (Q38599237) (← links)
- Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study. (Q38896036) (← links)
- Update on quality of life in patients with acromegaly (Q38978491) (← links)
- Psychosocial morbidity in acromegaly: a study from India (Q39860125) (← links)
- Diagnostic delay is associated with psychosocial impairment in acromegaly (Q40076638) (← links)
- Health-related quality of life in patients treated for nonfunctioning pituitary adenomas during the years 2000-2010. (Q40402022) (← links)
- Multi-modal management of acromegaly: a value perspective (Q41627761) (← links)
- Therapeutic options in the management of acromegaly: focus on lanreotide Autogel (Q43078115) (← links)
- Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study (Q43142513) (← links)
- Physical activities in daily life and functional capacity compared to disease activity control in acromegalic patients: impact in self-reported quality of life (Q43421079) (← links)
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update (Q44430611) (← links)
- Quality of life in female patients with acromegaly (Q45037737) (← links)
- Impact of exercise on quality of life and body-self perception of patients with acromegaly. (Q45199561) (← links)
- The partner's perspective of the impact of pituitary disease: Looking beyond the patient. (Q45977634) (← links)
- Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly. (Q47277169) (← links)
- Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas (Q47702268) (← links)
- Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? (Q47919183) (← links)
- Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort (Q47999814) (← links)
- The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL. (Q48021997) (← links)
- Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire (Q48054265) (← links)
- Endoscopic transphenoidal surgery for acromegaly improves quality of life (Q48058744) (← links)
- Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment (Q48070464) (← links)
- Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. (Q48081547) (← links)
- Impact of treatment satisfaction on quality of life of patients with acromegaly (Q48116018) (← links)